SCLXW
Scilex Holding Company
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.11
−5.47%Margins
Gross margin
41.5%
EBITDA margin
-1140.8%
EBIT margin
-903.5%
Net margin
-1414.6%
FCF margin
-56.7%
145.0%
Return on equity
-176.3%
Return on assets
134.2%
Return on invested capital
0.12x
Asset turnover
-$17.5M
Cash from operations
$0.05
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026